Connect with us

Markets & Investing

Post-Wonderland Debrief: H.C. Wainwright & Co.

The article Post-Wonderland Debrief: H.C. Wainwright & Co. was originally published on Microdose.

Running from November 8-9, 2021 in Miami, Wonderland…

Published

on

The article Post-Wonderland Debrief: H.C. Wainwright & Co. was originally published on Microdose.

Running from November 8-9, 2021 in Miami, Wonderland was an impressive collection of scientists and researchers, investors and entrepreneurs, therapists and patients, government officials, and media — all championing the growth of the psychedelic medicine industry.

From heavyweight celebrities like Mike Tyson, to the industry’s top companies and insiders, Wonderland was the sector’s largest in-person event. The psychedelic medicine industry has officially arrived and we’re proud to be a part of it.

Pulling off such a massive undertaking wouldn’t be possible without the support of our sponsors, they are crucial to both the Wonderland event and the future of the psychedelic medicine industry.

Here’s a summary of Headline and Official Banking Sponsor H.C. Wainwright & Co. and their participation at Wonderland.

In addition to their generous financial support, H.C. Wainwright also participated in an important industry panel:

“How to Place Value on Psychedelics Companies in an Evolving Landscape”

Panel abstract: Psychedelic companies have been getting large valuations very quickly. By talking to experts on all sides of the story: sell-side research analyst, independent financial consultant, and buy-side investment analyst, we should be able to gain more understanding of what these valuations mean, how they are calculated, and what makes a company in the psychedelic space potentially attractive investment.

H.C. Wainwright’s Patrick Trucchio participated in the panel, adding valuable insight.

Mr. Trucchio is a Managing Director of Equity Research at H.C. Wainwright whose research focuses on biotechnology, specifically on inflammation, fibrosis, cardio-metabolic, CNS, and rare diseases in addition to other areas. Mr. Trucchio has fourteen years of research experience on the sell-side. Prior to joining H.C. Wainwright, Mr. Trucchio was a senior equity research analyst at Berenberg Capital Markets (BCM) covering biotechnology and specialty pharmaceutical companies.

About the sponsor:

H.C. Wainwright & Co., LLC is a full-service investment bank based in New York City and one of the country’s oldest and most trusted financial institutions. H.C. Wainwright & Co. blends traditional values with innovative services, operating with integrity and offering leading-edge investment banking, corporate finance, and strategic advisory services to public and private growth companies across multiple sectors and regions.

H.C. Wainwright & Co. has been an invaluable partner in the psychedelic medicine industry’s growth and we thank them for their support.

“We are delighted to be supporting Microdose in this industry-leading event and to be a part of their mission to increase visibility for this growing and important sector.” – David Dinkin, Investment Banking, H.C. Wainwright & Co., LLC.

Read More

Trending